There is no universally agreed-upon “ideal” estrogen to progesterone ratio endorsed by major medical organizations. The ratio most commonly referenced in clinical practice is progesterone to estradiol (not total estrogen), and practitioners who use it generally consider a ratio of roughly 100:1 to 500:1 (progesterone to estradiol, both measured in the same units) to be a healthy range during the luteal phase of the menstrual cycle. A ratio around 200:1 is often cited as a reasonable midpoint. But these numbers come primarily from integrative and functional medicine practitioners, not from standardized guidelines issued by groups like the American College of Obstetricians and Gynecologists.
How the Ratio Is Calculated
The ratio compares progesterone (Pg) to estradiol (E2), with both values expressed in the same unit, typically picograms per milliliter (pg/mL). Since progesterone lab results often come back in nanograms per milliliter (ng/mL), you need to convert first: 1 ng/mL equals 1,000 pg/mL.
Here’s a worked example. If your progesterone is 20 ng/mL and your estradiol is 100 pg/mL, you would convert progesterone to 20,000 pg/mL, then divide by 100 pg/mL of estradiol. That gives you a Pg:E2 ratio of 200:1. The higher the number, the more progesterone you have relative to estradiol. A very low number suggests estrogen is dominant.
Why the Balance Matters More Than a Single Number
Estrogen and progesterone act as counterweights in your body. Estrogen stimulates the growth of your uterine lining each cycle, and progesterone keeps that growth in check. When progesterone is too low relative to estrogen, a state sometimes called estrogen dominance, the lining can thicken excessively. Over time, this imbalance disrupts the tightly coordinated hormonal regulation your body depends on.
The consequences go beyond one bad period. Chronic unopposed estrogen exposure is linked to endometrial hyperplasia (overgrowth of the uterine lining), which can progress to endometrial cancer. Research published in the journal Cells found that the accumulation of impaired progesterone signaling from one menstrual cycle to the next induces abnormal changes in the endometrium that can contribute to endometriosis, adenomyosis, polycystic ovary syndrome (PCOS), and implantation failure in women trying to conceive.
In PCOS specifically, chronic lack of ovulation means the endometrium faces prolonged estrogen exposure with no subsequent progesterone to counteract it. This is a well-documented pathway to endometrial hyperplasia. The pattern also plays a role in endometriosis, where estrogen promotes the growth of tissue outside the uterus while reduced progesterone response allows that growth to persist.
Signs Your Ratio May Be Off
You can’t diagnose estrogen dominance from symptoms alone, but certain patterns are worth paying attention to. Irregular periods with unpredictable timing, unusually heavy or light bleeding, breast tenderness, dense breast tissue, bloating, and mood changes can all signal that progesterone isn’t adequately balancing estrogen. Chronic pelvic pain, painful periods, and pain during intercourse are also associated with the hormonal imbalance that results from disrupted estrogen-progesterone signaling.
These symptoms overlap with many other conditions, which is part of why a blood test during the right time of your cycle is important. Progesterone peaks during the mid-luteal phase, roughly 7 days after ovulation, so testing at other points in your cycle will give misleadingly low progesterone readings and skew the ratio.
Why There’s No Official Target Range
If you’ve searched for this ratio hoping for a clear, medically endorsed number, you’ll find that one doesn’t exist. A review in the Journal of the American Board of Family Medicine noted plainly that “there are not well-defined goal ranges for hormones, and there is limited scientific evidence to support improved safety from monitoring” hormone levels to hit a specific target. This is true even in the context of hormone replacement therapy, where you might expect precise dosing goals.
The reason is partly biological. Hormone levels fluctuate dramatically throughout a single day, across your menstrual cycle, and from one cycle to the next. A snapshot blood draw captures one moment in a constantly shifting landscape. Two women with identical ratios on paper can have very different symptom profiles, and a woman with a “perfect” ratio on one blood draw may test differently three days later. Most clinicians treat the whole picture, symptoms, history, and lab trends together, rather than chasing a single number.
How the Ratio Shifts With Age
During your reproductive years, progesterone production depends on ovulation. Every time you ovulate, the structure left behind on the ovary (the corpus luteum) pumps out progesterone for roughly two weeks. If you don’t ovulate in a given cycle, progesterone stays low while estrogen may remain normal or even elevated. This is why anovulatory cycles, which become more common in your late 30s and 40s, tend to shift the ratio toward estrogen dominance.
Perimenopause accelerates this process. Ovulation becomes increasingly irregular, so progesterone drops faster and more unpredictably than estrogen does. Many of the hallmark symptoms of perimenopause, heavier periods, shorter cycles, worsening PMS, reflect this widening gap between the two hormones. After menopause, both hormones fall to very low levels, but the relative balance between them still matters for women using hormone therapy.
What to Do With This Information
If you’re tracking your hormones through a practitioner, ask for both progesterone and estradiol to be measured during the mid-luteal phase so the results are comparable. Salivary hormone tests and blood serum tests use different reference ranges, so make sure you’re comparing numbers drawn from the same type of test.
The 100:1 to 500:1 range gives you a rough framework, but it’s a clinical rule of thumb, not a diagnostic cutoff. A ratio below 100:1 during the luteal phase suggests progesterone may be relatively low, and that’s worth discussing with your provider, especially if you’re experiencing symptoms. But a ratio of 180:1 versus 220:1 is unlikely to be meaningfully different in practice. The trend over time and how you actually feel matter more than any single data point.
For women on hormone replacement therapy, the goal is typically to provide enough progesterone to protect the uterine lining from estrogen’s growth-promoting effects. Your provider will adjust doses based on symptoms, bleeding patterns, and periodic lab work rather than targeting a fixed ratio. If a practitioner insists on hitting an exact number without considering your symptoms, that’s worth questioning.